Normalized data in cleanroom microbial monitoring

Cleanroom manufacturing rules use Colony-Forming Units per cubic meter (CFU/m3) to measure active air sampling findings.

In grade A cleanroom environments, EU GMP Vol. 4 Annex 1 (2022 Revision) demands continuous active air monitoring during crucial processes, including the assembly/ set-up phase. A similar technique should be developed for Grade B situations.1

9.24 Continuous viable air monitoring in grade A (e.g. air sampling or settle plates) should be undertaken for the full duration of critical processing, including equipment (aseptic set-up) assembly and critical processing. A similar approach should be considered for grade B cleanrooms based on the risk of impact on the aseptic processing.

EU GMP Annex 1: 2022

As a result, the volume of sampled air in these places - which is strongly related to duration and flow rate - may exceed one cubic meter during the monitoring period.

It is not recommended to normalize air monitoring results to one m3 when the duration of a production process exceeds the time needed to sample one m3 of air. This applies to both viable and total particle counts. Specifically, for viable active air sampling, it is crucial to consider three significant parameters:

1. Contaminants are not uniformly distributed over time or in space

The environmental monitoring results represent a snapshot of circumstances at a specific time and are not repeatable.

Air flow, people movement, door openings, manufacturing activity, and local turbulence are all potential sources of brief contamination surges. Mathematically adjusting data to one m3 does not adequately reflect microbiological risk during sampling.

2. Colony Forming Units (CFUs) are distinct, non-fractionable units

Normalizing data to one m3 may result in non-whole values, which is contradictory with microorganisms as whole units (see point 3).

3. In grade A environments (most critical from the product point of view), the expected limit is ‘no growth.

In grade A conditions, the goal is not to achieve 0 CFU/m3, but to confirm the lack of growth. The key issue is to determine whether there is any growth, not how many colonies are in one m3. According to Annex 1 (Table 6, at paragraph 9.30), the criterion is non-detectable colonies:

Source: Particle Measuring Systems

Grade Air sample CFU /m3
A No growth(c)

(c) It should be noted that for grade A, any growth should result in an investigation.

Thus, normalized results with units of CFU/m3 are primarily useful for investigative purposes (to assess an impact on product quality) rather than routine monitoring evaluation, because the fractionalized result is unimportant in terms of SOP and regulatory requirements when conducting microbial investigations:

9.31 Microorganisms detected in the grade A and grade B areas should be identified to species level, and the potential impact of such microorganisms on product quality (for each batch implicated) and overall state of control should be evaluated.

EU GMP Annex 1, 2022

Recommended approach 

Instead of normalizing to one m3, the absolute number of CFUs identified alongside the sample volume should be reported.

This contextualizes the results, taking the sampling length and flow rate into account. This should be followed by an interpretative remark to back up the qualitative assessment of compliance, as quantitative compliance may not be applicable in such situations.

Note: Users should round up to the nearest whole number because a microbe (viable presence) cannot be fractionated, especially when determining its potential impact on product quality.

Examples

These samples in grades A and B reflect routine continuous sampling for four hours (240 minutes) at 25 LPM.

Grade A

  • Flow Rate: 25 L/min
  • Duration: four hours (240 min)
  • 1000 Liter (L) = 1 m3 (conversion factor for L to m3 = 1000)
  • Sampled volume = (Flow Rate x Duration) / (conversion factor) = (25 L/ min x 240 min) / (1000) = six m3
  • Result: two CFU on the plate after incubation

Recommended approach for data interpretation: 2 CFU in 6 m3

Qualitative assessment: investigation is necessary

Quality investigation:

  • Microbial identification is mandatory.
  • Mathematical calculation: 0.3 CFU/ m3 (2 CFU/ six m3) ≅ 1 CFU/ m3 (growth)
  • OUT OF ACTION LIMIT = DEVIATION (= process investigation for batch impact assessment

Grade B

First and foremost, in grade B regions, it is critical to assess the potential for influencing aseptic processing before starting continuous monitoring. The Annex 1 guidelines state:

“A similar approach should be considered for grade B cleanrooms based on the risk of impact on the aseptic processing.” (Ref. EU GMP Annex 1, 2022)

Continuous monitoring is not required in grade B areas; alternative options, such as 1 m3 sampling (for example, 40 min at 25 LPM) with a scheduled and process-related sampling frequency, may be adequate to cover the risk (such as the beginning, middle, and/ or end of manufacturing activities or during specific interventions/ transient events).

A risk assessment document is recommended to gather all essential information and develop a tailored sampling plan based on process requirements. Otherwise, in the event of continuous monitoring sampling, an alternative strategy might be:

  • Flow Rate: 25 Liter/ min
  • Duration: four hours (240 min)
  • 1000 Liter (L) = 1 m3 (conversion factor for L to m3 = 1000)
  • Sampled volume = (Flow Rate x Duration) / (conversion factor) = (25 L/min x 240 min) / (1000) = six m3
  • Result: 11 CFU on the plate after incubation

Recommended approach for data interpretation: 11 CFU in 6 m3

Qualitative assessment: investigation is necessary

Quality investigation:

  • Microbial identification is mandatory.
  • Mathematical calculation: 1.8 CFU/m3 (11 CFU/ six m3) ≅ 2 CFU/m3 (lower than 10 CFU/m3). This limit is in accordance with Annex 1 (Table 6, paragraph 9.30).
  • OUT OF ALARM LIMIT: deviation is not necessary at this phase, but process investigation is highly recommended.
    • This strategy requires assessment in accordance with the customer policy on deviations and the company’s contamination control strategies.
    • It is recommended to establish the same time frame for any deviation event because if an anomalous event (relevant to biologics or manufacturing) is highlighted, the occurred out-of-alert limit must be scaled up to a deviation (batch impact).

A note on alternatives to CFU/m3 in grade B environments 

When using an alternative technique to CFU/m3 sampling (e.g., continuous monitoring), it is critical to remember that out-of-alarm limit investigations should occur only occasionally. Microbial excursions in grade B environments should be minimal if a strong contamination control program is in place. Such excursions include effective cleaning, disinfection, maintenance, and monitoring procedures.

Normalizing data to per cubic meter (m3) is therefore not necessary under controlled settings. Effective trend analysis is vital to avoid the onset of more serious product quality issues.

As a result, monitoring procedures should include a trend analysis approach to evaluate, as a minimum, the following scenarios: expanding numbers of excursions from action limits or alert levels, recurrent excursions from alert levels, frequent but isolated excursions from action limits that may have a common reason (e.g. single excursions that consistently follow planned preventative maintenance), variations in microbial flora type, and quantity and dominance of specific organisms (refer to Annex 1, paragraph 9.11).

An adverse, or undesired, trend is defined as a sequence of data points that show an upward drift above the alert level and approach or exceed the action level compared to previous data.

Conclusions (PMS perspective) 

  • The non-homogeneous distribution of microorganisms, both in space and over time, raises concerns surrounding the use of only normalized data (CFU/m3), particularly in grade A environments.
  • In Grade B environments, conducting a risk assessment is recommended to determine possible effects on aseptic processing.
  • Normalized findings (CFU/ m3) can be useful for trend analysis, but lack microbiological relevance for routine monitoring. Microbial identification is usually required.
  • The most thorough and robust technique is presenting both the absolute CFU count and the normalized number, along with a technical explanation of their biological significance and regulatory implications.
  • Using trend analysis can help to prevent out-of-control incidents and improve product quality. Sporadic out-of-alarm occurrences may occur, although they are typically documented as indicators of a general control system drift. If a comprehensive contamination management strategy is in place, such excursions should be rare in Grade A and B workplaces. As a result, normalizing figures to per m3 should not be the major focus.
  • Effective process knowledge, preventative maintenance, adequate monitoring, and frequent reviews are essential for success. This gives customers assurance that the product’s quality will be maintained and guaranteed throughout time.

References

  1. European Commission (2022). The Rules Governing Medicinal Products in the European Union. Vol. 4 Good Manufacturing Practice Medicinal Products for Human and Veterinary Use – Annex 1 Manufacture of Sterile Medicinal Products. (online) European Commission. Available at: https://health.ec.europa.eu/medicinal-products/eudralex/eudralex-volume-4_en.

Acknowledgments

Produced using materials originally authored by Rosa Laronga, Giulia Paternò, and Serena Steidl, Advisory Specialists at Particle Measuring Systems.

About Particle Measuring Systems

Particle Measuring Systems has 35 years of experience designing, manufacturing, and servicing microcontamination monitoring instrumentation and software used for detecting particles in air, liquid, and gas streams, as well as molecular contamination monitoring.

Specific applications include cleanroom monitoring, parenteral sampling, filter and in-line testing in deionized water and process chemicals, and point-of-use monitoring of inert gases and in-situ particle monitoring. Specialty monitoring includes parts cleanliness testing with a highly automated solution.

Particle measuring systems

Whether you want to protect a product or meet industry requirements, such as ISO 14644, USP 797, or GMP, Particle Measuring Systems has a large variety of particle counters and molecular monitors to meet your needs. With 35 years of experience, it has proven reliability to support your application.

Particle counters

Protect your product with reliable particle counters. PMS has airborne, portable, and liquid particle counters for a wide variety of applications, including DI water, chemicals, and cleanroom monitoring. Compare particle counters or learn how to monitor your cleanroom or product by reading our papers.

Molecular contamination monitors

Molecular contamination causes costly problems for high-value products, production processes, and equipment surfaces. PMS has solutions for both Airborne Molecular contamination (AMC) and Surface Molecular contamination (SMC). With parts-per-trillion limits of detection, real-time sampling, NIST traceable calibrations, and various data analysis packages, you can monitor in confidence.

Gas detectors

If you need gas detectors for process control or continuous emissions monitoring, Particle Monitoring Systems can help. Get real-time, reliable results with its ammonia, hydrogen fluoride, and chlorine detectors for worker protection, CEMs, and pollution monitoring.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices, and treatments.

Last updated: Apr 30, 2026 at 9:01 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Particle Measuring Systems. (2026, April 30). Normalized data in cleanroom microbial monitoring. News-Medical. Retrieved on April 30, 2026 from https://www.news-medical.net/whitepaper/20260430/Normalized-data-in-cleanroom-microbial-monitoring.aspx.

  • MLA

    Particle Measuring Systems. "Normalized data in cleanroom microbial monitoring". News-Medical. 30 April 2026. <https://www.news-medical.net/whitepaper/20260430/Normalized-data-in-cleanroom-microbial-monitoring.aspx>.

  • Chicago

    Particle Measuring Systems. "Normalized data in cleanroom microbial monitoring". News-Medical. https://www.news-medical.net/whitepaper/20260430/Normalized-data-in-cleanroom-microbial-monitoring.aspx. (accessed April 30, 2026).

  • Harvard

    Particle Measuring Systems. 2026. Normalized data in cleanroom microbial monitoring. News-Medical, viewed 30 April 2026, https://www.news-medical.net/whitepaper/20260430/Normalized-data-in-cleanroom-microbial-monitoring.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.